MEK Inhibition: A New Ally in Immunotherapy for Intrahepatic Cholangiocarcinoma

Cell Mol Gastroenterol Hepatol. 2021;12(3):1153-1154. doi: 10.1016/j.jcmgh.2021.06.019. Epub 2021 Jul 6.
No abstract available

Publication types

  • Editorial
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Bile Duct Neoplasms* / drug therapy
  • Bile Ducts, Intrahepatic
  • Cholangiocarcinoma* / drug therapy
  • Humans
  • Immunotherapy
  • Mitogen-Activated Protein Kinase Kinases

Substances

  • Mitogen-Activated Protein Kinase Kinases